Afrin (oxymetazoline): Afrin (oxymetazoline) is fda pregnancy category c. Drugs.Com defines category c as “animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.” thus discuss with your ob/physician to determine if benefits outweigh risks.
Answered 11/1/2013
4.8k views
5 doctors weighed in across 4 answers
6 doctors weighed in across 2 answers
7 doctors weighed in across 3 answers
A doctor has provided 1 answer
A doctor has provided 1 answer
90,000 U.S. doctors in 147 specialties are here to answer your questions or offer you advice, prescriptions, and more.
Ask your question